Abiopharma

Rubrik to Report Second Quarter Fiscal 2027 Financial Results on August 27, 2026

Establishment Labs® Reports Second Quarter 2026 Financial Results

Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026

VoIP-Pal Granted Leave to File Amended Antitrust Complaint in D.C. Litigation

Edgewise Therapeutics Reports Second Quarter 2026 Financial Results

Kratos Receives U.S. Army Contract to Develop a Next-Generation Seeker for the Javelin Missile System

Sky Century Investment Inc. Commences the Development of AI-Powered Sleep Quality API

IMC Selects CoreWeave As Firm Deepens Research Investment

Providence™ Medical Technology Appoints Lane Major as President & Chief Executive Officer

ServiceNow Opens First Brazil Office; Expands Academic Partnerships to Build Regional AI Talent

Adtran launches Mosaic One Fabric, empowering operators to build custom AI agents and workflows

Theriva™ Biologics Announces First Patient Dosed in VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Quanterix To Participate in Canaccord Genuity Capital Markets 46th Annual Growth Conference on August 11-12

Marcus & Millichap, Inc. Reports Preliminary Results for Second Quarter 2026

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference